Friday, July 12, 2024

Stem Cells For Parkinson’s Disease Therapy

Parkinsons: Treating With Stem Cells

Stem Cell Therapy for Parkinson’s Disease

HOUSTON, Tx. More than ten million people worldwide are living with Parkinsons and 60,000 are in the U.S. Its a chronic, progressive disease that is classified as neuro-degenerative, which means it changes and continues to get worse over time. But a new therapy, currently in trials, is proving to be a game-changer. Treating Parkinsons

For Marie Bott, a few years ago this was impossible.

Its nice to know Im not flaring my arms around, Marie Bott told Ivanhoe.

Ten years ago, Marie was diagnosed with Parkinsons disease and as the disease progressed, she wasnt able to do the things she loves.

I totally lost my ability to swim. When I tried to swim, I would just go right to the bottom, Marie noted.

But then Marie was referred to a trial using stem cells to treat Parkinsons.

This kind of treatment approach will actually address maybe halting the progression of the disease, which would be very powerful, Mya Schiess, MD, director of the Movement Disorder Subspecialty Clinic at UTHealth Neurosciences Neurology, shared.

My skin became much younger looking, so much so that friends said to me had I changed my beauty regimen because I didnt appear to be so wrinkled, Marie exclaimed.

But she mostly credits the treatment for allowing her to continue her daily activities, like making breakfast and walking her dog.

To receive a free weekly e-mail on medical breakthroughs from Ivanhoe, sign up at:

What Causes Parkinson’s Disease

Parkinson’s Disease is caused by a loss of nerve cells in the brain. This loss of nerve cells within the brain results in a reduced amount of dopamine being created which acts as a messenger between the parts of your brain that control voluntary and involuntary movement. Therefore without that vital connection, your brain starts losing the ability to effectively control movement. Currently, it is unknown what causes the deterioration of nerve cells associated with Parkinson’s Disease . Currently, it is believed that both environmental factors, as well as genetic factors, may play a role in the loss of nerve cells.

Parkinson’s Disease is a lifelong condition that can greatly impair the ability of one’s daily functions. Traditional treatments only address the symptoms of the condition, but researchers are excited about the possibilities of certain gene therapies and stem cell therapy, which may have the ability to reverse damage and halt the progression of the disease.

We Can Assure You That Our Parkinsons Disease Treatment Has No Side Effects

Our capsule is free of amino acids and no manufactured hormones which destroy the production of hormones in the body. Parkinsons disease affected people should not wait because it occur many other complications to the person and the person cant lead a healthier life. So a person who has Parkinsons disease should start their treatment with Stem Cells Therapy to reduce the complications the person faces. It will improve your present condition as well as a healthier life ahead. To get the long-term benefit you should complete the full frame of Parkinsons disease treatment.

Read Also: Music Therapy For Parkinson’s

Advantages And Disadvantages Of Ipsc

Cell-based therapies including MSCs have been tested preclinically and clinically, and many results have shown them to correct a diseased state by replacing degenerating neurons with normal ones . The therapeutic benefits, however, may not be sustained for a satisfactory period of time owing to the presence of endogenous pathological proteins that might affect the transplanted functional cells . When -syn cellcell transfer occurred, -syncontaining LBs gradually appeared in grafted neurons .

Stem cell therapy for Parkinson disease. Dopaminergic progenitors could be obtained from different sources of pluripotent stem cells, which are either derived from somatic cells by epigenetic reprogramming, or from IVF-derived human embryos. HLA-matched iPSC or gene-edited hyopimmunogenic ESC/iPSC lowers the risk of graft-induced rejection. Preclinical tests in neurotoxin-induced PD models in rodents and nonhuman primates show promising therapeutic effect. IVF: in vitro fertilization HLA: human leukocyte antigen.

The New Hydrogel Technology

Stem Cells Parkinson

The new material is made of natural amino acids , and acts as a gateway to facilitate the safe transfer of stem cells to the brain and restore damaged tissue by releasing a growth protein called GDNF.

Nisbet explained that the natural amino acids make the hydrogel completely natural. It is also a smart system in the sense that it looks like a gel, and when it mixes with stem cells, it turns into a liquid that is injected into the brain through a very small capillary tube, and once inside, the hydrogel returns to its solid form. , providing support for stem cells to replace lost dopamine cells.

The team experimented with hydrogel technology on experimental mice, in which they inflicted neuronal injuries in the brain similar to Parkinsons, and the results showed increased survival of grafted dopamine neurons in the mice.

Nisbet sees this as an important finding, saying: The hydrogel successfully developed reverses the locomotion symptoms associated with Parkinsons disease injuries in animals.

We have observed a significant improvement in the animals paw movement and overall restoration of motor function.

You May Like: Caring For Someone With Parkinson’s

Genetic Testing For Parkinsons

Hereditary neurodegenerative diseases occur when genetic mutations are passed from the parents to their children. A genetic disease, however, can be due to environmental causes or hereditary. Random mutations can cause some genetic conditions in the DNA due to environmental factors or exposure to toxins. Familial PD accounts for less than 15% of all confirmed cases. Inherited parkinsonism is either an X-linked dominant pattern or autosomal recessive pattern. Each parent carries one copy of the mutated gene, but often do not show any signs or symptoms of the condition. For this reason, autosomal recessive PD can often be misdiagnosed dementia with Lewy bodies, multiple system atrophy or ALS/MND. The most common genetic markers used for screening hereditary Parkinsons include LRRK2, Glucocerebrosidase , RIC3, PARK2, PARK6, PARK7, SYNJ1, PTRHD1, TMEM230, UCHL1, DNAJC6, CYP2D6, VPS13C, PODXL, DNAJC13, CHCHD2, and RAB39B. Recent research also suggests that abnormalities in tau proteins are also a potential cause of familial parkinsonism and frontotemporal dementia.

The Regeneration center offers gene sequencing tests for 18 of the most common genes causes associated with Parkinsons disease and monogenic parkinsonism related conditions. The genes we can test for include: SLC6A3, LRRK2, DNAJC6, FBXO7, GCH1, PARK7, VPS35, PINK1, PRKRA, PRKN, SNCA, SPR, TH, CHCHD2, MAPT, ATP13A2, ATP7B & DCTN1

TREATMENT PRECAUTIONS & RISKS

Current Status Of Stem Cell

  • 1Neural Stem Cell Research Lab, Research Department, National Neuroscience Institute, Singapore, Singapore
  • 2Department of Diagnostic Radiology, Singapore General Hospital, Singapore, Singapore
  • 3Neuroscience & Behavioral Disorders Program, Duke University and National University of Singapore , Graduate Medical School, Singapore, Singapore
  • 4Department of Neurology, National Neuroscience Institute, Singapore General Hospital Campus, Singapore, Singapore
  • 5Lee Kong Chian School of Medicine, Nanyang Technological University, Novena Campus, Singapore, Singapore

Recommended Reading: What Kills A Person With Parkinson’s Disease

What Are The Advantages Of Human Umbilical Cord Mesenchymal Stem Cells

  • Abundant supply containing up to 10 times more stem cells than bone marrow or adipose derived stem cells
  • hUC-MSC have immunosuppressors and immunomodulatory properties that allow their use in any individual without rejection- Human Leukocyte Antigen matching is not necessary
  • Greater proliferation ability than adult autologous stem cells
  • They regenerate at a very rapid rate
  • They are young and very adaptive
  • They have not been impacted by the aging process
  • They have not been affected by environmental toxins
  • Umbilical cord stem cells can be administered multiple times over the course of days
  • Eliminates the need to collect stem cells from the patients fat or hip bone reducing pain and recovery time

Stem Cells Therapy In Parkinsons Disease Treatment

Webinar: Stem Cell Based Therapy for Parkinson’s Disease

Parkinsons disease is a long-term degenerative disorder. It occurs in the central nervous system. Symptoms of this disease come slowly over time. In the initial stage of this disease, people may face shaking, rigidity, slowness of movement, and difficulty with walking. If it occurs, Parkinsons disease treatment should be started immediately. Sometimes the patients also face thinking and behavioral problems. In the advanced stages of Parkinsons disease dementia becomes common. Depression and anxiety are also occurring with Parkinsons disease affected people. There are some more other symptoms may include such as sensory, sleep, and emotional problems.

Also Check: Parkinson’s And Boxing Connection

How Does Our Stem Therapy Treatment For Parkinsons Disease Process Work

All our stem cell treatments in Mexico are reviewed and administered by subject manner specialist in the area trained in US and Mexico, not just general doctors or physicians, to ensure the highest level of precision, understanding of the condition and quality of treatment for our patients. We are 100% clear and honest with our patients, not everyone is a candidate for our stem cell treatments, we turn-down many patients where the our specialist evaluates the current health condition and medical history and deems not a good fit for the treatment, to avoid false promises or expectations when the risks outweigh the benefits. For this reason and to ensure patient safety in all our treatments, all our patients get evaluated by the specialist before being able to schedule their treatment.

Step 1. Specialist Evaluation For Parkinsons Disease patients, our specialist will need to know the patients age and previous medical treatments. In addition, will need to review specific tests you will be asked to bring.

Step 2. Specialist Phone Consultation Once the specialist has reviewed the medical records and approved your case, we will present options and pricing, at which point we will also offer a free phone consultation to discuss questions and concerns.

Step 5. Treatment Follow-up Our follow up specialist will check in with you according to our follow up calendar for your specific treatment to ensure you have all the tools at your disposal for maximum benefits.

Stem Cell Research And Parkinsons

The aim of stem cell research in Parkinsons is to understand how nerve cells develop, why some die and how healthy cells can be used to replace damaged brain cells. With this knowledge it may be possible to replace the damaged cells in the brain by introducing healthy dopamine-producing cells generated from stem cells grown in the laboratory. Healthy dopamine-producing cells derived from stem cells could also be useful to researchers in testing new treatments.

Researchers are particularly interested in embryonic stem cells as they have the potential to develop into all types of cells in the body, including the brain. More research is needed in order to understand the way these cells work to ensure that replication can be controlled and a safe treatment developed.

You May Like: Drugs Prescribed For Parkinson’s Disease

Why We Believe This

Stem cells have the potential to develop into every kind of cell found in the body.

This means that stem cells could be used to treat a wide range of conditions, including Parkinson’s, where new cells could be used to repair and replace damaged tissue.

Scientists have been able to turn stem cells into dopamine-producing nerve cells the type of brain cells affected in Parkinson’s.

What Are Stem Cell Lines

Stem Cell Therapy, Parkinson

A stem cell line is a family of constantly dividing cells, the product of a single parent group of stem cells. They are obtained from human or animal tissues and have been manipulated in a laboratory so that they have the ability to divide almost indefinitely, creating the line.

Because stem cell lines produce so many copies of themselves , this means that scientists have a large bank of cells for their research and are less likely to need to take cells from an embryo repeatedly. Of course, it is important that researchers are also able to stop such cell lines dividing at some point so that they can generate tissue specific cells, such as for the brain in the case of Parkinsons treatment. The challenge for researchers is to discover how they can control the process which causes stem cells to differentiate.

Also Check: How Do You Treat Parkinson’s Disease Naturally

Patients Comfort During The Procedures

Medical procedures are carried out in a calm and comfortable environment in compliance with the established norms and conditions.

In the case of collecting the patients own cells, the harvesting is performed in the operating room. At this stage, the patient may feel a slight pain, similar to the usual sensation from an injection when the doctor introduces an anaesthetic. After the procedure, there may be minor and short-term discomfort associated with the invasiveness of the procedure .

However, for older patients, the use of cultured stem cells obtained from donor sources is recommended. This minimizes the risks associated with the harvesting of biomaterial, and it also makes treatment more tolerable.

Both when using patients own or donated cells , the introduction of MSCs is no different from the introduction of other drugs.

For therapy, a standardised injection of a cell product is used, while the patient is in a relaxed state within 1-2 hours.

Stem Cells For Parkinsons: Therapy And Tools For A Neurological Disorder

This is a guest post from The Michael J. Fox Foundation for Parkinsons Research . MJFF is committed to the pursuit of a Parkinsons cure and better quality of life for those living with the disease today. Stem cells are valuable tools in that work, helping develop new therapies and learn more about the disease. Find out more about the work they do at www.michaeljfox.org.

Parkinson’s disease is a neurological disorder that affects one in 100 people over age 60. The disease causes a variety of symptoms including motor problems such as tremors, muscle rigidity and slowed movement, and non-motor symptoms of cognitive impairment, mood disorders, and autonomic dysfunction. It is estimated that nearly 1 million people in the United States and more than 6 million worldwide have Parkinsons disease. Current treatments can ease some symptoms, but no available therapies stop or slow the progression of the disease.

Scientists are using stem cells to better understand and treat Parkinsons disease.

Stem Cell TreatmentsIn Parkinsons disease , cells that make the chemical messenger dopamine degenerate and die. Introducing new dopamine cells into the brain may help replace what is lost in PD and reduce its symptoms. Such a treatment also could reduce medication side effects. Long-term use of the most commonly prescribed PD medication and progressing disease can lead to dyskinesia or uncontrolled, involuntary movements.

What Types Of Cells Are Used In Parkinsons Disease Stem Cell Treatment

TruStem Cell Therapy provides access to treatment that utilizes a patients stem cells isolated from their own bone marrow. There are multiple inherent benefits afforded by the utilization of bone marrow derived stem cells as Bone marrow and bone marrow components function in various diverse, innate therapeutic capacities.

Hematopoietic stem cells , found within BM, are the bodys source of most cells found in the peripheral or circulating blood. These include red blood cells and white blood cells . Evidence suggests that BM-derived monocytes may act to improve certain neurodegenerative conditions. In this disease environment exhausted microglia cannot efficiently clear A deposits, leading to peptide buildup and neurodegeneration. In this state, monocytes easily bypass the compromised blood-brain-barrier, adhere to A positive veins, then phagocytose and transport peptide from the brain microvasculature into the circulating blood.

In addition to HSCs, mesenchymal stem cells are also contained within BM. Evidence suggests MSCs can enter the circulating blood during injury and have been shown to readily home to areas of injury or inflammation. Once at these damaged tissue sites, MSCs can exert both protective cellular and immunomodulatory effects believed to be critical in many neurological conditions.

Conventional Parkinson Disease Therapies Vs Stem Cell Therapy

Stem Cell Therapy for Parkinson’s Disease – testimonial

Parkinsons Disease is a chronic neurodegenerative disorder caused by selective and gradual loss of dopamine-producing neurons. These neurons are spread throughout the brain, however, the most effected region is the substantia nigra. The symptoms of Parkinson’s Disease are mainly tremor and rigor. At later stages the illness is characterized by more severe symptoms like speech disorder, depression or even dementia. Currently, there is no cure for Parkinsons disease. Nevertheless, there are few hormone replacement-based therapies which tackle the symptoms only. These pharmacological treatments are effective to control the symptoms of PD to a certain degree, with side effects, but are unable to stop neural degeneration, let alone replace dead dopaminergic cells.

Degeneration of dopaminergic neurons in Parkinson’s DiseaseANOVA IRM Germany, © DOI: 10.3389/fnins.2018.00080

Stem cell research has allowed ANOVA, a German Stem Cell Clinic in the heart of Europe near Frankfurt/Main airport, to offer a novel treatment with a new therapeutical approach: The ANOVA Stem Cell Secretome is a cell free and promising treatment option for AD. , whether you wish to apply for a treatment, or simply receive more information.

The Future Of Stem Cell Therapy For Parkinsons

Four groups dedicated to using stem cell therapies to treat Parkinsons disease have formed an international consortium known as G Force PD. Each of the four centers is planning a clinical trial to start in the next 1-4 years. They differ on the source of stem cells that they will be using . All will be injecting the cells directly into the basal ganglia part of the brain where the ends of the dopamine producing neurons live. The Parkinsons community eagerly awaits the implementation of these trials.

When open for enrollment, should I consider participating in a stem cell trial?When faced with an illness like PD, you can at times feel that it is worthwhile to try anything that may lead to a cure. Its important to always make sure however, that youre dealing with trusted information, proven therapies, and clinical trials that have been properly vetted by the medical community.

Therefore, in order to use clinicaltrials.gov safely, focus on the trials conducted at academic medical centers in the United States. Once you have identified a trial that you might be interested in, talk it over with your doctor before committing to anything.

Be aware that a clinical trial utilizing stem cells will likely require the cells to be injected directly into the brain, which will inevitably be associated with a certain amount of risk. You will need to discuss details of this risk with your doctor and the trial organizers.

Popular Articles
Related news